Patents 293show all

  • 70
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 41
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 37
    G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
  • 28
    B01L - Chemical or physical laboratory apparatus for general use
  • 11
    B82Y - Specific uses or applications of nanostructures
  • 10
    B03C - Magnetic or electrostatic separation of solid materials from solid materials or fluids
  • 7
    C12M - Apparatus for enzymology or microbiology
  • 6
    G06F - Electric digital data processing
  • 5
    B33Y - Additive manufacturing, i.e. manufacturing of three-dimensional [3-d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3-d printing, stereolithography or selective laser sintering
  • 4
    G16C - Computational chemistry

Clinical Trials 3show all

SEC Filings show all


4
D

Contact Information

Redwood City, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-05-10$750,000$750,000Equity, Option to Acquire, Security to be Acquired
2011-08-01$48,449,975$46,449,975Equity
2009-10-15$10,000,000$9,000,000Equity
2008-10-23Unknown Unknown Other (Paper Filing)

Key Executives

  • Richard Rava
    Executive Officer, Director
  • Jeff Bird
    Director
  • Bill Ericson
    Director
  • Michael Hunkapiller
    Director
  • Phyllis Whiteley
    Director
  • Caren Mason
    Executive Officer, Director
  • Caren L. Mason
    Executive Officer, Director
  • Alfred Merriweather
    Executive Officer